Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Safety-feasibility Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

NCT06447376 is registered in ClinicalTrials.gov with Taylor Brooks as lead sponsor.

NCT NCT06447376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06447376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Safety-feasibility Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Lead sponsor
Taylor Brooks
Phase
Phase 1
Overall status
Recruiting
Start date
January 14, 2025
Completion date
September 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokine release syndrome, non-hodgkin lymphoma